These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11188780)

  • 1. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
    Cazzola M
    Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact and management of anaemia in haematological malignancies.
    Coiffier B
    Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and chronic lymphocytic leukemia.
    Mauro FR; Gentile M; Foa R
    Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
    Osterbor A
    Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
    Monnerat C; Leyvraz S
    Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alfa-epoietin and anaemia in gynaecological cancer.
    Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
    Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin in the treatment of head and neck tumour anaemia.
    Oettle H; Riess H; Raguse JD; Bier J; Gath HJ
    Int J Oral Maxillofac Surg; 2001 Apr; 30(2):148-55. PubMed ID: 11405451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma.
    Dammacco F; Luccarelli G; Prete M; Silvestris F
    Rev Clin Exp Hematol; 2002; Suppl 1():32-8. PubMed ID: 12735213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of epoetin in the management of anaemia in patients with lung cancer.
    Morère JF
    Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaemia in diabetes.
    Thomas S; Rampersad M
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S13-7. PubMed ID: 15103543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoetin beta therapy in patients with solid tumours.
    Pronzato P; Jassem J; Mayordomo J
    Crit Rev Oncol Hematol; 2006 Apr; 58(1):46-52. PubMed ID: 16169242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of human recombinant erythropoietin in children with cancer].
    Guyot D; Margueritte G
    Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer.
    Dempke W
    Anticancer Res; 2007; 27(4A):1745-57. PubMed ID: 17649769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rHuEPO and improved treatment outcomes: potential modes of action.
    Blackwell K; Gascón P; Sigounas G; Jolliffe L
    Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
    Desai J; Demetri GD
    Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial.
    Auerbach M; Ballard H; Trout JR; McIlwain M; Ackerman A; Bahrain H; Balan S; Barker L; Rana J
    J Clin Oncol; 2004 Apr; 22(7):1301-7. PubMed ID: 15051778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?
    Osterborg A
    Med Oncol; 1998 Aug; 15 Suppl 1():S47-9. PubMed ID: 9785337
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anemia in patients with cancer].
    Kobune M; Kato J; Niitsu Y
    Nihon Rinsho; 2008 Mar; 66(3):524-9. PubMed ID: 18330028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in the therapeutic use of erythropoiesis stimulating agents.
    Jelkmann W
    Br J Haematol; 2008 May; 141(3):287-97. PubMed ID: 18410567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rHuEPO and treatment outcomes: the clinical experience.
    Hudis CA; Van Belle S; Chang J; Muenstedt K
    Oncologist; 2004; 9 Suppl 5():55-69. PubMed ID: 15591423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.